
|Articles|March 31, 2021
Reltio Launches Enterprise 360 Site Intelligence
Advertisement
Reltio, a cloud-native master data management software provider, has introduced Reltio Enterprise 360 Site Intelligence. The software centralizes detailed data about study sites and principal investigators. Features include the ability to search all current, complete, accurate information available on healthcare organizations/ study sites, and HCP/PIs; evaluate and rate study sites and principal investigators using artificial intelligence (AI), quantitative metrics, and qualitative criteria, and manage consent, contracting, and collaboration workflows.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
5



